Global Alzheimer's drugs Market Size, Share, Growth Analysis Report - Forecast 2034
Alzheimer's drugs Market By Drug class (Donepezil, Galantamine, Rivastigmine, Memantine, Others), By Distribution channel (Hospital Pharmacy, Retail Pharmacy, Online Stores, Others), and By Region: Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034
Category: Pharmaceutical Report Format : PDF
Pages: 188 Report Code: ZMR-2513
Published Date: Apr-2025 Status : Published
| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 5.19 Billion | USD 13.91 Billion | 10.5% | 2024 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Alzheimer’s drugs Market, (2022 - 2028) (USD Billion)
- 2.2 Global Alzheimer’s drugs Market : snapshot
- Chapter 3. Global Alzheimer’s drugs Market - Industry Analysis
- 3.1 Alzheimer’s drugs Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Increasing Research and Development Activity
- 3.3 Market Restraints
- 3.3.1. Discontinuation of Clinical Trials to Hamper Alzheimer’s drugs Market growth
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Drug class
- 3.7.2 Market attractiveness analysis By Distribution channel
- Chapter 4. Global Alzheimer’s drugs Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Alzheimer’s drugs Market: company market share, 2021
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Alzheimer’s drugs Market - Drug class Analysis
- 5.1 Global Alzheimer’s drugs Market overview: By Drug class
- 5.1.1 Global Alzheimer’s drugs Market share, By Drug class, 2021 and 2028
- 5.2 Donepezil
- 5.2.1 Global Alzheimer’s drugs Market by Donepezil, 2022 - 2028 (USD Billion)
- 5.3 Galantamine
- 5.3.1 Global Alzheimer’s drugs Market by Galantamine, 2022 - 2028 (USD Billion)
- 5.4 Rivastigmine
- 5.4.1 Global Alzheimer’s drugs Market by Rivastigmine, 2022 - 2028 (USD Billion)
- 5.5 Memantine
- 5.5.1 Global Alzheimer’s drugs Market by Memantine, 2022 - 2028 (USD Billion)
- 5.6 Others
- 5.6.1 Global Alzheimer’s drugs Market by Others, 2022 - 2028 (USD Billion)
- 5.1 Global Alzheimer’s drugs Market overview: By Drug class
- Chapter 6. Global Alzheimer’s drugs Market - Distribution channel Analysis
- 6.1 Global Alzheimer’s drugs Market overview: By Distribution channel
- 6.1.1 Global Alzheimer’s drugs Market share, By Distribution channel, 2021 and 2028
- 6.2 Hospital Pharmacy
- 6.2.1 Global Alzheimer’s drugs Market by Hospital Pharmacy, 2022 - 2028 (USD Billion)
- 6.3 Retail Pharmacy
- 6.3.1 Global Alzheimer’s drugs Market by Retail Pharmacy, 2022 - 2028 (USD Billion)
- 6.4 Online Stores
- 6.4.1 Global Alzheimer’s drugs Market by Online Stores, 2022 - 2028 (USD Billion)
- 6.5 Others
- 6.5.1 Global Alzheimer’s drugs Market by Others, 2022 - 2028 (USD Billion)
- 6.1 Global Alzheimer’s drugs Market overview: By Distribution channel
- Chapter 7. Alzheimer’s drugs Market - Regional Analysis
- 7.1 Global Alzheimer’s drugs Market Regional Overview
- 7.2 Global Alzheimer’s drugs Market Share, by Region, 2021 & 2028 (USD Billion)
- 7.3. North America
- 7.3.1 North America Alzheimer’s drugs Market, 2022 - 2028 (USD Billion)
- 7.3.1.1 North America Alzheimer’s drugs Market, by Country, 2022 - 2028 (USD Billion)
- 7.3.1 North America Alzheimer’s drugs Market, 2022 - 2028 (USD Billion)
- 7.4 North America Alzheimer’s drugs Market, by Drug class, 2022 - 2028
- 7.4.1 North America Alzheimer’s drugs Market, by Drug class, 2022 - 2028 (USD Billion)
- 7.5 North America Alzheimer’s drugs Market, by Distribution channel, 2022 - 2028
- 7.5.1 North America Alzheimer’s drugs Market, by Distribution channel, 2022 - 2028 (USD Billion)
- 7.4. Europe
- 7.4.2 Europe Alzheimer’s drugs Market, 2022 - 2028 (USD Billion)
- 7.4.2.1 Europe Alzheimer’s drugs Market, by Country, 2022 - 2028 (USD Billion)
- 7.4.2 Europe Alzheimer’s drugs Market, 2022 - 2028 (USD Billion)
- 7.4 Europe Alzheimer’s drugs Market, by Drug class, 2022 - 2028
- 7.4.1 Europe Alzheimer’s drugs Market, by Drug class, 2022 - 2028 (USD Billion)
- 7.5 Europe Alzheimer’s drugs Market, by Distribution channel, 2022 - 2028
- 7.5.1 Europe Alzheimer’s drugs Market, by Distribution channel, 2022 - 2028 (USD Billion)
- 7.5. Asia Pacific
- 7.5.3 Asia Pacific Alzheimer’s drugs Market, 2022 - 2028 (USD Billion)
- 7.5.3.1 Asia Pacific Alzheimer’s drugs Market, by Country, 2022 - 2028 (USD Billion)
- 7.5.3 Asia Pacific Alzheimer’s drugs Market, 2022 - 2028 (USD Billion)
- 7.4 Asia Pacific Alzheimer’s drugs Market, by Drug class, 2022 - 2028
- 7.4.1 Asia Pacific Alzheimer’s drugs Market, by Drug class, 2022 - 2028 (USD Billion)
- 7.5 Asia Pacific Alzheimer’s drugs Market, by Distribution channel, 2022 - 2028
- 7.5.1 Asia Pacific Alzheimer’s drugs Market, by Distribution channel, 2022 - 2028 (USD Billion)
- 7.6. Latin America
- 7.6.4 Latin America Alzheimer’s drugs Market, 2022 - 2028 (USD Billion)
- 7.6.4.1 Latin America Alzheimer’s drugs Market, by Country, 2022 - 2028 (USD Billion)
- 7.6.4 Latin America Alzheimer’s drugs Market, 2022 - 2028 (USD Billion)
- 7.4 Latin America Alzheimer’s drugs Market, by Drug class, 2022 - 2028
- 7.4.1 Latin America Alzheimer’s drugs Market, by Drug class, 2022 - 2028 (USD Billion)
- 7.5 Latin America Alzheimer’s drugs Market, by Distribution channel, 2022 - 2028
- 7.5.1 Latin America Alzheimer’s drugs Market, by Distribution channel, 2022 - 2028 (USD Billion)
- 7.7. The Middle-East and Africa
- 7.7.5 The Middle-East and Africa Alzheimer’s drugs Market, 2022 - 2028 (USD Billion)
- 7.7.5.1 The Middle-East and Africa Alzheimer’s drugs Market, by Country, 2022 - 2028 (USD Billion)
- 7.7.5 The Middle-East and Africa Alzheimer’s drugs Market, 2022 - 2028 (USD Billion)
- 7.4 The Middle-East and Africa Alzheimer’s drugs Market, by Drug class, 2022 - 2028
- 7.4.1 The Middle-East and Africa Alzheimer’s drugs Market, by Drug class, 2022 - 2028 (USD Billion)
- 7.5 The Middle-East and Africa Alzheimer’s drugs Market, by Distribution channel, 2022 - 2028
- 7.5.1 The Middle-East and Africa Alzheimer’s drugs Market, by Distribution channel, 2022 - 2028 (USD Billion)
- Chapter 8. Company Profiles
- 8.1 Abbvie Inc.
- 8.1.1 Overview
- 8.1.2 Financials
- 8.1.3 Product Portfolio
- 8.1.4 Business Strategy
- 8.1.5 Recent Developments
- 8.2 AstraZeneca PLC
- 8.2.1 Overview
- 8.2.2 Financials
- 8.2.3 Product Portfolio
- 8.2.4 Business Strategy
- 8.2.5 Recent Developments
- 8.3 Biogen Inc.
- 8.3.1 Overview
- 8.3.2 Financials
- 8.3.3 Product Portfolio
- 8.3.4 Business Strategy
- 8.3.5 Recent Developments
- 8.4 Daiichi Sankyo Company Limited
- 8.4.1 Overview
- 8.4.2 Financials
- 8.4.3 Product Portfolio
- 8.4.4 Business Strategy
- 8.4.5 Recent Developments
- 8.5 Daiichi Sankyo Company Limited
- 8.5.1 Overview
- 8.5.2 Financials
- 8.5.3 Product Portfolio
- 8.5.4 Business Strategy
- 8.5.5 Recent Developments
- 8.6 Eisai Co. Ltd.
- 8.6.1 Overview
- 8.6.2 Financials
- 8.6.3 Product Portfolio
- 8.6.4 Business Strategy
- 8.6.5 Recent Developments
- 8.7 Eli Lilly and Company
- 8.7.1 Overview
- 8.7.2 Financials
- 8.7.3 Product Portfolio
- 8.7.4 Business Strategy
- 8.7.5 Recent Developments
- 8.8 H. Lundbeck A/S
- 8.8.1 Overview
- 8.8.2 Financials
- 8.8.3 Product Portfolio
- 8.8.4 Business Strategy
- 8.8.5 Recent Developments
- 8.9 F. Hoffmann-La Roche AG
- 8.9.1 Overview
- 8.9.2 Financials
- 8.9.3 Product Portfolio
- 8.9.4 Business Strategy
- 8.9.5 Recent Developments
- 8.10 Merck & Co. Inc.
- 8.10.1 Overview
- 8.10.2 Financials
- 8.10.3 Product Portfolio
- 8.10.4 Business Strategy
- 8.10.5 Recent Developments
- 8.11 Novartis AG
- 8.11.1 Overview
- 8.11.2 Financials
- 8.11.3 Product Portfolio
- 8.11.4 Business Strategy
- 8.11.5 Recent Developments
- 8.12 Ono Pharmaceutical Co. Ltd.
- 8.12.1 Overview
- 8.12.2 Financials
- 8.12.3 Product Portfolio
- 8.12.4 Business Strategy
- 8.12.5 Recent Developments
- 8.13 Pfizer Inc
- 8.13.1 Overview
- 8.13.2 Financials
- 8.13.3 Product Portfolio
- 8.13.4 Business Strategy
- 8.13.5 Recent Developments
- 8.14 Teva Pharmaceutical Industries Limited
- 8.14.1 Overview
- 8.14.2 Financials
- 8.14.3 Product Portfolio
- 8.14.4 Business Strategy
- 8.14.5 Recent Developments
- 8.1 Abbvie Inc.
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global Alzheimer’s drugs Market, 2022 - 2028 (USD Billion)
- 4. Porter’s Five Forces Analysis
- 5. Global Alzheimer’s drugs Market attractiveness, By Drug class
- 6. Global Alzheimer’s drugs Market attractiveness, By Distribution channel
- 7. Global Alzheimer’s drugs Market share by Drug class, 2022 and 2028 (USD Billion)
- 8. Global Alzheimer’s drugs Market by Donepezil, 2022 - 2028 (USD Billion)
- 9. Global Alzheimer’s drugs Market by Galantamine, 2022 - 2028 (USD Billion)
- 10. Global Alzheimer’s drugs Market by Rivastigmine, 2022 - 2028 (USD Billion)
- 11. Global Alzheimer’s drugs Market by Memantine, 2022 - 2028 (USD Billion)
- 12. Global Alzheimer’s drugs Market by Others, 2022 - 2028 (USD Billion)
- 13. Global Alzheimer’s drugs Market share by Distribution channel, 2022 and 2028 (USD Billion)
- 14. Global Alzheimer’s drugs Market by Hospital Pharmacy, 2022 - 2028 (USD Billion)
- 15. Global Alzheimer’s drugs Market by Retail Pharmacy, 2022 - 2028 (USD Billion)
- 16. Global Alzheimer’s drugs Market by Online Stores, 2022 - 2028 (USD Billion)
- 17. Global Alzheimer’s drugs Market by Others, 2022 - 2028 (USD Billion)
- 18. Global Alzheimer’s drugs Market share, by Region, 2022 and 2028
- 19. North America Alzheimer’s drugs Market, 2022 - 2028 (USD Billion)
- 20. Europe Alzheimer’s drugs Market, 2022 - 2028 (USD Billion)
- 21. Asia Pacific Alzheimer’s drugs Market, 2022 - 2028 (USD Billion)
- 22. Latin America Alzheimer’s drugs Market, 2022 - 2028 (USD Billion)
- 23. The Middle-East and Africa Alzheimer’s drugs Market, 2022 - 2028 (USD Billion)
Table Of Tables
- 1. Global Alzheimer’s drugs Market: Snapshot
- 2. Drivers of the Alzheimer’s drugs Market: impact analysis
- 3. North America Alzheimer’s drugs Market revenue, By Drug class, 2022 - 2028 (USD Billion)
- 4. North America Alzheimer’s drugs Market revenue, By Distribution channel, 2022 - 2028 (USD Billion)
- 5. U.S. Alzheimer’s drugs Market revenue, By Drug class, 2022 - 2028 (USD Billion)
- 6. U.S. Alzheimer’s drugs Market revenue, By Distribution channel, 2022 - 2028 (USD Billion)
- 7. Canada Alzheimer’s drugs Market revenue, By Drug class, 2022 - 2028 (USD Billion)
- 8. Canada Alzheimer’s drugs Market revenue, By Distribution channel, 2022 - 2028 (USD Billion)
- 9. Europe Alzheimer’s drugs Market revenue, By Drug class, 2022 - 2028 (USD Billion)
- 10. Europe Alzheimer’s drugs Market revenue, By Distribution channel, 2022 - 2028 (USD Billion)
- 11. Germany Alzheimer’s drugs Market revenue, By Drug class, 2022 - 2028 (USD Billion)
- 12. Germany Alzheimer’s drugs Market revenue, By Distribution channel, 2022 - 2028 (USD Billion)
- 13. France Alzheimer’s drugs Market revenue, By Drug class, 2022 - 2028 (USD Billion)
- 14. France Alzheimer’s drugs Market revenue, By Distribution channel, 2022 - 2028 (USD Billion)
- 15. U.K. Alzheimer’s drugs Market revenue, By Drug class, 2022 - 2028 (USD Billion)
- 16. U.K. Alzheimer’s drugs Market revenue, By Distribution channel, 2022 - 2028 (USD Billion)
- 17. Italy Alzheimer’s drugs Market revenue, By Drug class, 2022 - 2028 (USD Billion)
- 18. Italy Alzheimer’s drugs Market revenue, By Distribution channel, 2022 - 2028 (USD Billion)
- 19. Spain Alzheimer’s drugs Market revenue, By Drug class, 2022 - 2028 (USD Billion)
- 20. Spain Alzheimer’s drugs Market revenue, By Distribution channel, 2022 - 2028 (USD Billion)
- 21. Rest of Europe Alzheimer’s drugs Market revenue, By Drug class, 2022 - 2028 (USD Billion)
- 22. Rest of Europe Alzheimer’s drugs Market revenue, By Distribution channel, 2022 - 2028 (USD Billion)
- 23. Asia Pacific Alzheimer’s drugs Market revenue, By Drug class, 2022 - 2028 (USD Billion)
- 24. Asia Pacific Alzheimer’s drugs Market revenue, By Distribution channel, 2022 - 2028 (USD Billion)
- 25. China Alzheimer’s drugs Market revenue, By Drug class, 2022 - 2028 (USD Billion)
- 26. China Alzheimer’s drugs Market revenue, By Distribution channel, 2022 - 2028 (USD Billion)
- 27. Japan Alzheimer’s drugs Market revenue, By Drug class, 2022 - 2028 (USD Billion)
- 28. Japan Alzheimer’s drugs Market revenue, By Distribution channel, 2022 - 2028 (USD Billion)
- 29. India Alzheimer’s drugs Market revenue, By Drug class, 2022 - 2028 (USD Billion)
- 30. India Alzheimer’s drugs Market revenue, By Distribution channel, 2022 - 2028 (USD Billion)
- 31. South Korea Alzheimer’s drugs Market revenue, By Drug class, 2022 - 2028 (USD Billion)
- 32. South Korea Alzheimer’s drugs Market revenue, By Distribution channel, 2022 - 2028 (USD Billion)
- 33. South-East Asia Alzheimer’s drugs Market revenue, By Drug class, 2022 - 2028 (USD Billion)
- 34. South-East Asia Alzheimer’s drugs Market revenue, By Distribution channel, 2022 - 2028 (USD Billion)
- 35. Rest of Asia Pacific Alzheimer’s drugs Market revenue, By Drug class, 2022 - 2028 (USD Billion)
- 36. Rest of Asia Pacific Alzheimer’s drugs Market revenue, By Distribution channel, 2022 - 2028 (USD Billion)
- 37. Latin America Alzheimer’s drugs Market revenue, By Drug class, 2022 - 2028 (USD Billion)
- 38. Latin America Alzheimer’s drugs Market revenue, By Distribution channel, 2022 - 2028 (USD Billion)
- 39. Brazil Alzheimer’s drugs Market revenue, By Drug class, 2022 - 2028 (USD Billion)
- 40. Brazil Alzheimer’s drugs Market revenue, By Distribution channel, 2022 - 2028 (USD Billion)
- 41. Mexico Alzheimer’s drugs Market revenue, By Drug class, 2022 - 2028 (USD Billion)
- 42. Mexico Alzheimer’s drugs Market revenue, By Distribution channel, 2022 - 2028 (USD Billion)
- 43. Rest of Latin America Alzheimer’s drugs Market revenue, By Drug class, 2022 - 2028 (USD Billion)
- 44. Rest of Latin America Alzheimer’s drugs Market revenue, By Distribution channel, 2022 - 2028 (USD Billion)
- 45. The Middle-East and Africa Alzheimer’s drugs Market revenue, By Drug class, 2022 - 2028 (USD Billion)
- 46. The Middle-East and Africa Alzheimer’s drugs Market revenue, By Distribution channel, 2022 - 2028 (USD Billion)
- 47. GCC Countries Alzheimer’s drugs Market revenue, By Drug class, 2022 - 2028 (USD Billion)
- 48. GCC Countries Alzheimer’s drugs Market revenue, By Distribution channel, 2022 - 2028 (USD Billion)
- 49. South Africa Alzheimer’s drugs Market revenue, By Drug class, 2022 - 2028 (USD Billion)
- 50. South Africa Alzheimer’s drugs Market revenue, By Distribution channel, 2022 - 2028 (USD Billion)
- 51. Rest of Middle-East Africa Alzheimer’s drugs Market revenue, By Drug class, 2022 - 2028 (USD Billion)
- 52. Rest of Middle-East Africa Alzheimer’s drugs Market revenue, By Distribution channel, 2022 - 2028 (USD Billion)
Methodology
FrequentlyAsked Questions
The global alzheimer's drugs market is expected to grow due to rising prevalence of alzheimer’s disease, increasing r&d investments, and new drug developments.
According to a study, the global alzheimer's drugs market size was worth around USD 5.19 Billion in 2024 and is expected to reach USD 13.91 Billion by 2034.
The global alzheimer's drugs market is expected to grow at a CAGR of 10.5% during the forecast period.
North America is expected to dominate the alzheimer's drugs market over the forecast period.
Leading players in the global alzheimer's drugs market include Abbvie Inc., AstraZeneca PLC, Biogen Inc., Daiichi Sankyo Company Limited, Daiichi Sankyo Company Limited, Eisai Co. Ltd., Eli Lilly and Company, H. Lundbeck A/S, F. Hoffmann-La Roche AG, Merck & Co. Inc., Novartis AG, Ono Pharmaceutical Co. Ltd., Pfizer Inc and Teva Pharmaceutical Industries Limited, among others.
The report explores crucial aspects of the alzheimer's drugs market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients
